Long-Term Assets: The sum of all assets classified as non-current.
Portage Biotech Inc. (PRTG) had Long-Term Assets of $0.02M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-1.36M |
|
-- |
|
-- |
|
$1.61M |
|
$-1.61M |
|
$0.25M |
|
$-1.36M |
|
$-1.36M |
|
$-1.36M |
|
$-1.36M |
|
$-1.36M |
|
$-1.36M |
|
$-1.61M |
|
$-1.61M |
|
1.08M |
|
1.08M |
|
$-1.26 |
|
$-1.26 |
|
| Balance Sheet Financials | |
$2.69M |
|
-- |
|
|
Long-Term Assets |
$0.02M |
$2.71M |
|
$0.87M |
|
-- |
|
$1.14M |
|
$2.01M |
|
$0.69M |
|
$0.69M |
|
$0.69M |
|
1.12M |
|
| Cash Flow Statement Financials | |
$-3.25M |
|
-- |
|
$-0.02M |
|
$5.03M |
|
$1.76M |
|
$-3.26M |
|
$0.28M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.08 |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.25M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-195.97% |
|
-195.97% |
|
-50.33% |
|
-195.97% |
|
$0.62 |
|
$-3.02 |
|
$-3.02 |
|